Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Cidara Therapeutics, Inc. has filed 798 SEC EDGAR filings since 17 Jun 2014

SEC filing history

Showing 651-675 of 798 matching filings.

Per page
25
Current page
27
SC 13G File 005-88806

SC 13G filing

Filing date
13 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Jun 2017
Reporting date
22 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-36912

CT ORDER filing

Filing date
26 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2017
Reporting date
22 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2017
Reporting date
22 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2017
Reporting date
22 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2017
Reporting date
22 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36912

RESULTS OF ANNUAL MEETING OF STOCKHOLDERS

Filing date
23 Jun 2017
Reporting date
22 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88806

SCHEDULE 13G

Filing date
16 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jun 2017
Reporting date
06 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Jun 2017
Reporting date
05 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36912

CIDARA THERAPEUTICS, INC. FORM 10-Q

Filing date
10 May 2017
Reporting date
31 Mar 2017
Next action
Verify source filing
8-K File 001-36912

FORM 8-K

Filing date
10 May 2017
Reporting date
10 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36912

2017 PROXY NOTICE

Filing date
28 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36912

2017 PROXY STATEMENT

Filing date
28 Apr 2017
Reporting date
22 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36912

8-K

Filing date
06 Apr 2017
Reporting date
06 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2017
Reporting date
31 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2017
Reporting date
31 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2017
Reporting date
31 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2017
Reporting date
31 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2017
Reporting date
31 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2017
Reporting date
31 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2017
Reporting date
16 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 Apr 2017
Reporting date
14 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2017
Reporting date
31 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .